SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-22-005592
Filing Date
2022-04-21
Accepted
2022-04-21 16:00:10
Documents
2
Group Members
KEVIN TANGTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 ASLAN PHARMACEUTICALS LTD. o419223sc13g.htm SC 13G 86641
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 7968
  Complete submission text file 0001214659-22-005592.txt   96220
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001232621 (see all company filings)

IRS No.: 461592449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Subject) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91181 | Film No.: 22841367
SIC: 2834 Pharmaceutical Preparations